Wednesday, 04 November 2009 20:41
Shorter Radiation Course Stops Cancer Growth in High-risk Prostate Cancer Patients
Hypofractionated radiation treatment, a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy, is significantly more effective than the older method in stopping cancer growth in high risk patients and causes no increase in negative side effects, an Italian clinical trial shows.
Wednesday, 04 November 2009 18:42
Short Course High-Dose Radiation (IMRT) Looks Safe and Effective for Higher-Risk Prostate Cancer
ASTRO - A shorter, 5-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears just as effective and as safe for moderate and higher risk prostate cancer as standard radiation therapy, yet is delivered in two-and-a-half weeks less time.
MRI Guided Biopsy to Find "Hidden" Prostate Tumors
Scans for diagnosis and staging - MRI-Magnetic Resonance Imaging
Thursday, 08 October 2009 18:00
Why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer? Clinical researchers at Princess Margaret Hospital (PMH) in Toronto, Canada believe they can now answer that baffling question.
Monday, 05 October 2009 13:09
NSAID Made No Difference to Cancer Growth
To see whether Celebrex (celecoxib) can reduce prostate cancer size and spread, a team from several leading US cancer centers led by Dr. Alan Partin and Dr. Michael Carducci conducted a randomized, double-blind trial enrolling high-risk men before primary treatment with surgery or radiation. They measured the effect of celecoxib on drug-specific biomarkers from prostate tissue obtained at prostatectomy on these men.
Friday, 18 September 2009 06:27
Dr. Gerald Chodak outlines controversy over antiandrogens
Men fighting metastatic prostate cancer may be frustrated to discover that doctors disagree with one another. For example, a lot of controversy surrounds the question of whether to block male hormones from the adrenal gland by use of a drug such as bicalutamide (Casodex). In a video, Dr. Gerald Chodak, a Chicago urologist, discusses how to maximize survival.
More Articles...
Page 3 of 9
